Assessing herb–drug interactions of herbal products with therapeutic agents for metabolic diseases: analytical and regulatory perspectives S Nanjappan, D Paul, L Bolla Studies in natural products chemistry 59, 283-322, 2018 | 22 | 2018 |
Cytochrome P450 and P-gp mediated herb-drug interactions and molecular docking studies of garcinol L Bolla, P Srivastava, V Ravichandiran, SK Nanjappan Membranes 11 (12), 992, 2021 | 10 | 2021 |
Nimbolide loaded sustained release microparticles as single-dose formulations for effective management of arthritis P Anchi, S Chilvery, S Tekalkar, SNR Gajula, R Sonti, C Godugu Journal of Drug Delivery Science and Technology, 103638, 2022 | 3 | 2022 |
Significance of Stability and Pharmacokinetic Issues in Traditional Medicine L Bolla, NR Gangireddy, DNJ Bale, S Nanjappan Evidence Based Validation of Traditional Medicines: A comprehensive Approach …, 2021 | | 2021 |
P69-Pharmacokinetic interaction study of novel combination of HMG co-a reductase inhibitor with green coffee bean formulation for obesity associated complications in SD rats … L Bolla, P Johnsi Rani, A Kavati, S Nanjappan Drug Metabolism and Pharmacokinetics 35 (1), S42, 2020 | | 2020 |
Interactions of herbal slimming agents with CYP Substrates: an in vitro study using human liver microsomes S Nanjappan, L Bolla, P Srivastava Drug Metabolism and Pharmacokinetics 34 (1), S55, 2019 | | 2019 |